A Comprehensive Review on Machine Learning and Deep Learning Methods in Drug Discovery

Main Article Content

Sneha Khaire
Dr. Pawan Bhaladhare


Due to its ability to drastically cut the time and money required to develop new medicines, artificial intelligence (AI) based drug discovery has recently attracted a lot of attention. The fields of drug research and development have made use of machine learning (ML) and deep learning (DL) technologies to develop new medication prospects. Machine learning and deep learning-based techniques are emerging at every level of the drug development process as a result of the proliferation of drug-related data. Preclinical testing of a target of interest has proven to be particularly tough for pharmaceutical chemists, who face significant challenges in selecting and developing effective drugs. Machine learning and deep learning algorithms are now extensively used in approaches for generating therapeutic targets and innovative medication development in order to increase the accuracy, efficiency, and quality of created outputs. This review focuses on the application of machine learning and deep learning algorithms in drug development, as well as related approaches. We'll look at the approaches and methods that seem most promising in terms of their potential impact.

Article Details

How to Cite
Sneha Khaire, and Dr. Pawan Bhaladhare. “A Comprehensive Review on Machine Learning and Deep Learning Methods in Drug Discovery”. International Journal on Recent and Innovation Trends in Computing and Communication, vol. 10, no. 10, Oct. 2022, pp. 01-08, doi:10.17762/ijritcc.v10i10.5728.


Reddy, A.S.; Zhang, S. Polypharmacology: Drug discovery for the future. Expert Rev. Clin. Pharmacol. 2013, 6, 41–47.

Sachdev, K.; Gupta, M.K. A comprehensive review of feature-based methods for drug target interaction prediction. J. Biomed. Inform. 2019, 93, 103159.

Vamathevan, J.; Clark, D.; Czodrowski, P.; Dunham, I.; Ferran, E.; Lee, G.; Li, B.; Madabhushi, A.; Shah, P.; Spitzer, M.; et al. Applications of machine learning in drug discovery and development. Nat. Rev. Drug Discov. 2019, 18, 463–477.

Kimber, T.B.; Chen, Y.; Volkamer, A. Deep learning in virtual screening: Recent applications and developments. Int. J. Mol. Sci. 2021, 22, 4435.

Lipinski, C.F.; Maltarollo, V.G.; Oliveira, P.R.; da Silva, A.B.F.; Honorio, K.M. Advances, and Perspectives in Applying Deep Learning for Drug Design and Discovery. Front. Robot. AI 2019, 6, 108.

Rifaioglu, A.S.; Atas, H.; Martin, M.J.; Cetin-Atalay, R.; Atalay, V.; Do?gan, T. Recent applications of deep learning and machine intelligence on in silico drug discovery: Methods, tools, and databases. Brief. Bioinform. 2019, 20, 1878–1912.

Zhavoronkov, A.; Ivanenkov, Y.A.; Aliper, A.; Veselov, M.S.; Aladinskiy, V.A.; Aladinskaya, A.V.; Terentiev, V.A.; Polykovskiy, D.A.; Kuznetsov, M.D.; Asadulaev, A.; et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat. Biotechnol. 2019, 37, 1038–1040.

Feng, Q.; Dueva, E.; Cherkasov, A.; Ester, M. PADME: A Deep Learning-Based Framework for Drug-Target Interaction Prediction. arXiv 2018, arXiv:1807.09741.

Skalic, M.; Varela-Rial, A.; Jiménez, J.; Martínez-Rosell, G.; De Fabritiis, G. LigVoxel: Inpainting binding pockets using 3Dconvolutional neural networks. Bioinformatics 2019, 35, 243–250.

Fayyad, J.; Jaradat, M.A.; Gruyer, D.; Najjaran, H. Deep Learning Sensor Fusion for Autonomous Vehicle Perception and Localization: A Review. Sensors 2020, 20, 4220.

Deng, L.; Li, X. Machine Learning Paradigms for Speech Recognition: An Overview. IEEE Trans. Audio Speech Lang. Process. 2013, 21, 1060–1089.

Afouras, T.; Chung, J.S.; Senior, A.; Vinyals, O.; Zisserman, A. Deep Audio-visual Speech Recognition. IEEE Trans. Pattern Anal. Mach. Intell. 2018, 1.

Joachims, T.; Radlinski, F. Search Engines that Learn from Implicit Feedback. Computer 2007, 40, 34–40.

Lo, Y.C.; Rensi, S.E.; Torng, W.; Altman, R.B. Machine learning in chemoinformatics and drug discovery. Drug Discov. Today 2018, 23, 1538–1546.

Talevi, A.; Morales, J.F.; Hather, G.; Podichetty, J.T.; Kim, S.; Bloomingdale, P.C.; Kim, S.; Burton, J.; Brown, J.D.; Winterstein, A.G.; et al. Machine Learning in Drug Discovery and Development Part 1: A Primer. CPT Pharmacomet. Syst. Pharmacol. 2020, 9, 129–142.

Gertrudes, J.C.; Maltarollo, V.G.; Silva, R.A.; Oliveira, P.R.; Honório, K.M.; da Silva, A.B. Machine learning techniques and drug design. Curr. Med. Chem. 2012, 19, 4289–4297.

Agarwal, S.; Dugar, D.; Sengupta, S. Ranking chemical structures for drug discovery: A new machine learning approach. J. Chem. Inf. Model. 2010, 50, 716–731.

Rodrigues, T.; Bernardes, G.J.L. Machine learning for target discovery in drug development. Curr. Opin. Chem. Biol. 2020, 56, 16–22.

Gao, D.; Chen, Q.; Zeng, Y.; Jiang, M.; Zhang, Y. Application of Machine Learning on Drug Target Discovery. Curr. Drug Metab. 2020.

Vamathevan, J.; Clark, D.; Czodrowski, P.; Dunham, I.; Ferran, E.; Lee, G.; Li, B.; Madabhushi, A.; Shah, P.; Spitzer, M.; et al. Applications of machine learning in drug discovery and development. Nat. Rev. Drug Discov. 2019, 18, 463–477.

Zo_mann, S.; Vercruysse, M.; Benmansour, F.; Maunz, A.; Wolf, L.; Marti, R.B.; Heckel, T.; Ding, H.; Truong, H.H.; Prummer, M.; et al. Machine learning-powered antibiotics phenotypic drug discovery. Sci. Rep. 2019, 9, 5013.

Ekins, S.; Puhl, A.C.; Zorn, K.M.; Lane, T.R.; Russo, D.P.; Klein, J.J.; Hickey, A.J.; Clark, A.M. Exploiting machine learning for end-to-end drug discovery and development. Nat. Mater. 2019, 18, 435–441.

Khamis, M.A.; Gomaa, W.; Ahmed, W.F. Machine learning in computational docking. Artif. Intell. Med. 2015, 63, 135–152.

Leelananda, S.P.; Lindert, S. Computational methods in drug discovery. Beilstein J. Org. Chem. 2016, 12, 2694–2718.

Maia, E.H.B.; Assis, L.C.; de Oliveira, T.A.; da Silva, A.M.; Taranto, A.G. Structure-Based Virtual Screening: From Classical to Artificial Intelligence. Front. Chem. 2020, 8, 343.

Talambedu, U.; Shanmugarajan, D.; Goyal, A.K.; Kumar, C.S.; Middha, S.K. Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift. Curr. Top. Med. Chem. 2017, 17, 3296–3307.

Réda, C.; Kaufmann, E.; Delahaye-Duriez, A. Machine learning applications in drug development. Comput. Struct. Biotechnol. J. 2020, 18, 241–252.

Breiman, L. Random Forests. Mach. Learn. 2001, 45, 5–32.

Webb, G.I. Naïve Bayes. In Encyclopedia of Machine Learning; Sammut, C., Webb, G.I., Eds.; Springer: Boston, MA, USA, 2010.

Cortes, C.; Vapnik, V. Support-vector networks. Mach. Learn. 1995, 20, 273–297.

Rifaioglu, A.S.; Atas, H.; Martin, M.J.; Cetin-Atalay, R.; Atalay, V.; Do?gan, T. Recent applications of deep learning and machine intelligence on in silico drug discovery: Methods, tools, and databases. Brief Bioinform. 2019, 20, 1878–1912.

Dugger, S.A.; Platt, A.; Goldstein, D.B. Drug development in the era of precision medicine. Nat. Rev. Drug Discov. 2018, 17, 183–196.

Hulsen, T.; Jamuar, S.S.; Moody, A.R.; Karnes, J.H.; Varga, O.; Hedensted, S.; Spreafico, R.; Hafler, D.A.; McKinney, E.F. From Big Data to Precision Medicine. Front. Med. 2019, 6, 34.

Liu, B.; He, H.; Luo, H.; Zhang, T.; Jiang, J. Artificial intelligence and big data facilitated targeted drug discovery. Stroke Vasc. Neurol. 2019, 4, 206.

Cirillo, D.; Valencia, A. Big data analytics for personalized medicine. Curr. Opin. Biotechnol. 2019, 58, 161–167.

Kaiser, T.M.; Burger, P.B. Error Tolerance of Machine Learning Algorithms across Contemporary Biological Targets. Molecules 2019, 24, 2115.

LeCun, Y.; Bengio, Y.; Hinton, G. Deep learning. Nature 2015, 521, 436–444.

Dana, D.; Gadhiya, S.V.; St Surin, L.G.; Li, D.; Naaz, F.; Ali, Q.; Paka, L.; Yamin, M.A.; Narayan, M.; Goldberg, I.D. Deep Learning in Drug Discovery and Medicine; Scratching the Surface. Molecules 2018, 23, 2384.

Korotcov, A.; Tkachenko, V.; Russo, D.P.; Ekins, S. Comparison of Deep Learning with Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets. Mol. Pharm. 2017, 14, 4462–4475.

Ekins, S. The Next Era: Deep Learning in Pharmaceutical Research. Pharm. Res. 2016, 33, 2594–2603.

D’Souza, S.; Prema, K.V.; Balaji, S. Machine learning models for drug-target interactions: Current knowledge and future directions. Drug Discov. Today 2020, 25, 748–756.

Baskin, I.I.; Winkler, D.; Tetko, I.V. A renaissance of neural networks in drug discovery. Expert Opin. Drug Discov. 2016, 11, 785–795.

Verma, J.; Khedkar, V.M.; Coutinho, E.C. 3D-QSAR in drug design—A review. Curr. Top. Med. Chem. 2010, 10, 95–115.

Ghasemi, F.; Mehridehnavi, A.; Pérez-Garrido, A.; Pérez-Sánchez, H. Neural network and deep-learning algorithms used in QSAR studies: Merits and drawbacks. Drug Discov. Today 2018, 23, 1784–1790.

Srivastava, N.; Hinton, G.; Krizhevsky, A.; Sutskever, I.; Salakhutdinov, R. Dropout: A simple way to Prevent Neural Networks from Overfitting. J. Mach. Learn. Res. 2014, 15, 1929–1958.

Chen, H.; Engkvist, O.;Wang, Y.; Olivecrona, M.; Blaschke, T. The rise of deep learning in drug discovery. Drug Discov. Today 2018, 23, 1241–1250.

Popova, M.; Isayev, O.; Tropsha, A. Deep reinforcement learning for de novo drug design. Sci. Adv. 2018, 4, eaap7885.

Yuan, W.; Jiang, D.; Nambiar, D.K.; Liew, L.P.; Hay, M.P.; Bloomstein, J.; Lu, P.; Turner, B.; Le, Q.T.; Tibshirani, R.; et al. Chemical Space Mimicry for Drug Discovery. J. Chem. Inf. Model. 2017, 57, 875–882.

Gupta, A.; Müller, A.T.; Huisman, B.J.H.; Fuchs, J.A.; Schneider, P.; Schneider, G. Generative Recurrent Networks for De Novo Drug Design. Mol. Inf. 2018, 37, 1700111.

Segler, M.H.S.; Kogej, T.; Tyrchan, C.; Waller, M.P. Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks. ACS Cent. Sci. 2018, 4, 120–131.

De Almeida, A.F.; Moreira, R.; Rodrigues, T. Synthetic organic chemistry driven by artificial intelligence. Nat. Rev. Chem. 2019, 3, 589–604.

Chan, H.C.S.; Shan, H.; Dahoun, T.; Vogel, H.; Yuan, S. Advancing Drug Discovery via Artificial Intelligence. Trends Pharmacol. Sci. 2019, 40, 592–604.

Segler, M.H.S.; Preuss, M.; Waller, M.P. Planning chemical syntheses with deep neural networks and symbolic AI. Nature 2018, 555, 604–610.

Segler, M.H.S.; Waller, M.P. Neural-Symbolic Machine Learning for Retrosynthesis and Reaction Prediction. Chem. Eur. J. 2017, 23, 5966–5971.

Zhou, Z.; Li, X.; Zare, R.N. Optimizing Chemical Reactions with Deep Reinforcement Learning. ACS Cent. Sci. 2017, 3, 1337–1344.

Coley, C.W.; Barzilay, R.; Jaakkola, T.S.; Green, W.H.; Jensen, K.F. Prediction of Organic Reaction Outcomes Using Machine Learning. ACS Cent. Sci. 2017, 3, 434–443.

Lee, A.A.; Yang, Q.; Sresht, V.; Bolgar, P.; Hou, X.; Klug-McLeod, J.L.; Butler, C.R. Molecular Transformer unifies reaction prediction and retrosynthesis across pharma chemical space. Chem. Commun. 2019, 55, 12152–12155.

Chen, C.; Shi, H.; Han, Y.; Jiang, Z.; Cui, X.; Yu, B. DNN-DTIs: Improved drug-target interactions prediction using XGBoost feature selection and deep neural network. bioRxiv 2020.

Xie, L.; He, S.; Song, X.; Bo, X.; Zhang, Z. Deep learning-based transcriptome data classification for drug-target interaction prediction. BMC Genomics 2018, 19, 13–16.

Korkmaz, S. Deep learning-based imbalanced data classification for drug discovery. J. Chem. Inf. Model. 2020, 60, 4180–4190.

Dr. D. P. Kothari. (2022). Development of Multimedia Signal Processing and Its Technology. Acta Energetica, (02), 36–43. Retrieved from http://actaenergetica.org/index.php/journal/article/view/467

Hassan-Harrirou, H.; Zhang, C.; Lemmin, T. RosENet: Improving Binding Affinity Prediction by LeveragingMolecular Mechanics Energies with an Ensemble of 3D Convolutional Neural Networks. J. Chem. Inf. Model. 2020, 60, 2791–2802.

Rifaioglu, A.S.; Atalay, V.; Martin, M.J.; Cetin-Atalay, R.; Do?gan, T. DEEPScreen: High-performance drug-target interaction prediction with convolutional neural networks using 2-D structural compound representations. bioRxiv 2018, 491365.

Lee, I.; Keum, J.; Nam, H. DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences. PLoS Comput. Biol. 2019, 15, 1–21.

Pu, L.; Govindaraj, R.G.; Lemoine, J.M.; Wu, H.-C.; Brylinski, M. DeepDrug3D: Classification of ligand-binding pockets in proteins with a convolutional neural network. PLoS Comput. Biol. 2019, 15, e1006718.

Townshend, R.J.L.; Powers, A.; Eismann, S.; Derry, A. ATOM3D: Tasks On Molecules in Three Dimensions. arXiv 2021, arXiv:2012.04035.

Kwon, Y.; Shin, W.H.; Ko, J.; Lee, J. AK-score: Accurate protein-ligand binding affinity prediction using an ensemble of 3D-convolutional neural networks. Int. J. Mol. Sci. 2020, 21, 1–16.

Huang, K.; Fu, T.; Glass, L.M.; Zitnik, M.; Xiao, C.; Sun, J. DeepPurpose: A deep learning library for drug–target interaction prediction. Bioinformatics 2020, 36, 5545–5547.

Karpov, P.; Godin, G.; Tetko, I.V. Transformer-CNN: Swiss knife for QSAR modeling and interpretation. J. Cheminform. 2020, 12,17.

Scarselli, F.; Gori, M.; Tsoi, A.C.; Hagenbuchner, M.; Monfardini, G. The graph neural network model. IEEE Trans. Neural Networks 2009, 20, 61–80.

Sun, M.; Zhao, S.; Gilvary, C.; Elemento, O.; Zhou, J.; Wang, F. Graph convolutional networks for computational drug development and discovery. Brief. Bioinform. 2020, 21, 919–935.

Chen, X.; Liu, X.; Wu, J. GCN-BMP: Investigating graph representation learning for DDI prediction task. Methods 2020, 179, 47–54.

Liu, K.; Sun, X.; Jia, L.; Ma, J.; Xing, H.; Wu, J.; Gao, H.; Sun, Y.; Boulnois, F.; Fan, J. Chemi-net: A molecular graph convolutional network for accurate drug property prediction. Int. J. Mol. Sci. 2019, 20, 3389.

Long, Y.; Wu, M.; Liu, Y.; Kwoh, C.K.; Luo, J.; Li, X. Ensembling graph attention networks for human microbe-drug association prediction. Bioinformatics 2020, 36, I779–I786.

Zhang, J.; Jiang, Z.; Hu, X.; Song, B. A novel graph attention adversarial network for predicting disease-related associations Methods 2020, 179, 81–88.

Rolf Bracke, & Nouby M. Ghazaly. (2022). An Exploratory Study of Sharing Research Energy Resource Data and Intellectual Property Law in Electrical Patients. Acta Energetica, (01), 01–07. Retrieved from http://actaenergetica.org/index.php/journal/article/view/459

Lim, J.; Hwang, S.Y.; Moon, S.; Kim, S.; Kim, W.Y. Scaffold-based molecular design with a graph generative model. Chem. Sci. 2020, 11, 1153–1164.

Hochreiter, S. The vanishing gradient problem during learning recurrent neural nets and problem solutions. Int. J. Uncertain Fuzziness Knowlege-Based Syst. 1998, 6, 107–116.

Yu, Y.; Si, X.; Hu, C.; Zhang, J. A review of recurrent neural networks: Lstm cells and network architectures. Neural Comput. 2019, 31, 1235–1270.

Mouchlis, V.D.; Afantitis, A.; Serra, A.; Fratello, M.; Papadiamantis, A.G.; Aidinis, V.; Lynch, I.; Greco, D.; Melagraki, G. Advances in de novo drug design: From conventional to machine learning methods. Int. J. Mol. Sci. 2021, 22, 1–22.

Cho, K.; Van Merriënboer, B.; Gulcehre, C.; Bahdanau, D.; Bougares, F.; Schwenk, H.; Bengio, Y. Learning phrase representations using RNN encoder-decoder for statistical machine translation. In Proceedings of the EMNLP 2014 Conference on Empirical Methods in Natural Language Processing, Doha, Qatar, 25–29 October 2014; pp. 1724–1734.

Jastrz?ebski, S.; Le´sniak, D.; Czarnecki, W.M. Learning to SMILE(S). arXiv 2016, arXiv:1602.06289.

Guimaraes, G.L.; Sanchez-Lengeling, B.; Outeiral, C.; Farias, P.L.C.; Aspuru-Guzik, A. Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation Models. arXiv 2017, arXiv:1705.10843.

De Cao, N.; Kipf, T. MolGAN: An implicit generative model for small molecular graphs. arXiv 2018, arXiv:1805.11973.

Devlin, J.; Chang, M.W.; Lee, K.; Toutanova, K. BERT: Pre-training of deep bidirectional transformers for language understanding. In Proceedings of the NAACL HLT Annual Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies, Minneapolis, MN, USA, 2–7 June 2019; Volume 1, pp. 4171–4186.

Lennox, M.; Robertson, N.M.; Devereux, B. Modelling Drug-Target Binding Affinity using a BERT based Graph Neural network. Annu. Rev. Biochem. 2021, 68, 559–581.

Goodfellow, I.; Pouget-Abadie, J.; Mirza, M.; Xu, B.; Warde-Farley, D.; Ozair, S.; Courville, A.; Bengio, Y. Generative adversarial networks. Commun. ACM 2020, 63, 139–144.

Lin, E.; Lin, C.H.; Lane, H.Y. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery. Molecules 2020, 25, 3250.

Yu, L.; Zhang, W.; Wang, J.; Yu, Y. SeqGAN: Sequence generative adversarial nets with policy gradient. In Proceedings of the 31 AAAI Conference on Artificial Intelligence, San Francisco, CA, USA, 4–9 February 2017; pp. 2852–2858.

Peng, J.; Li, J.; Shang, X. A learning-based method for drug-target interaction prediction based on feature representation learning and deep neural network. BMC Bioinform. 2020, 21, 1–13.

Gómez-Bombarelli, R.; Wei, J.N.; Duvenaud, D.; Hernández-Lobato, J.M.; Sánchez-Lengeling, B.; Sheberla, D.; Aguilera-Iparraguirre, J.; Hirzel, T.D.; Adams, R.P.; Aspuru-Guzik, A. Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules. ACS Cent. Sci. 2018, 4, 268–276.

Makhzani, A.; Shlens, J.; Jaitly, N.; Goodfellow, I.; Frey, B. Adversarial Autoencoders. arXiv 2015, arXiv:1511.05644.

Vanhaelen, Q.; Lin, Y.C.; Zhavoronkov, A. The Advent of Generative Chemistry. ACS Med. Chem. Lett. 2020, 11, 1496–1505.

Kadurin, A.; Aliper, A.; Kazennov, A.; Mamoshina, P.; Vanhaelen, Q.; Khrabrov, K.; Zhavoronkov, A. The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology. Oncotarget 2017, 8, 10883–10890.

Kadurin, A.; Nikolenko, S.; Khrabrov, K.; Aliper, A.; Zhavoronkov, A. DruGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico. Mol. Pharm. 2017, 14, 3098–3104.

Polykovskiy, D.; Zhebrak, A.; Vetrov, D.; Ivanenkov, Y.; Aladinskiy, V.; Mamoshina, P.; Bozdaganyan, M.; Aliper, A.; Zhavoronkov, A.; Kadurin, A. Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery. Mol. Pharm. 2018, 15, 4398–4405.